A药品名称: B药品名称: B与A对换
 药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
A药品
B药品
详细
Tadalafil
Pridinol
The risk or severity of adverse effects can be increased when Levetiracetam is combined with Pridinol.
Tadalafil
Fabomotizole
The risk or severity of adverse effects can be increased when Levetiracetam is combined with Fabomotizole.
Tadalafil
Phenazocine
The risk or severity of adverse effects can be increased when Levetiracetam is combined with Phenazocine.
Tadalafil
Phenoperidine
The risk or severity of adverse effects can be increased when Levetiracetam is combined with Phenoperidine.
Tadalafil
Oxiracetam
The risk or severity of adverse effects can be increased when Levetiracetam is combined with Oxiracetam.
Tadalafil
Naftidrofuryl
The risk or severity of adverse effects can be increased when Levetiracetam is combined with Naftidrofuryl.
Tadalafil
Allobarbital
The risk or severity of adverse effects can be increased when Levetiracetam is combined with Allobarbital.
Tadalafil
Emylcamate
The risk or severity of adverse effects can be increased when Levetiracetam is combined with Emylcamate.
Tadalafil
Thiopropazate
The risk or severity of adverse effects can be increased when Levetiracetam is combined with Thiopropazate.
Tadalafil
Moperone
The risk or severity of adverse effects can be increased when Levetiracetam is combined with Moperone.
Tadalafil
Trifluperidol
The risk or severity of adverse effects can be increased when Levetiracetam is combined with Trifluperidol.
Tadalafil
Bifemelane
The risk or severity of adverse effects can be increased when Levetiracetam is combined with Bifemelane.
Tadalafil
Iprazochrome
The risk or severity of adverse effects can be increased when Levetiracetam is combined with Iprazochrome.
Tadalafil
Gedocarnil
The risk or severity of adverse effects can be increased when Levetiracetam is combined with Gedocarnil.
Tadalafil
Veralipride
The risk or severity of adverse effects can be increased when Levetiracetam is combined with Veralipride.
Tadalafil
Mebicar
The risk or severity of adverse effects can be increased when Levetiracetam is combined with Mebicar.
Tadalafil
Metergoline
The risk or severity of adverse effects can be increased when Levetiracetam is combined with Metergoline.
Tadalafil
Emepronium
The risk or severity of adverse effects can be increased when Levetiracetam is combined with Emepronium.
Tadalafil
Iprindole
The risk or severity of adverse effects can be increased when Levetiracetam is combined with Iprindole.
Tadalafil
Meptazinol
The risk or severity of adverse effects can be increased when Levetiracetam is combined with Meptazinol.
免责声明:以上所展示的信息由企业自行提供,内容的真实性、准确性和合法性由发布企业负责,医药网对此不承担任何责任。
相关链接:医药研究数据| 医药资料| SDA药品评审中心| 中医网| 中药处方系统| 爱视立眼贴
专业提供药品信息、药品招商、药品代理、保健品招商、医药原料采购供应的中国药品信息网站平台
版权所有 © 2003-2028 盗冒必究  客服热线:0575-83552251 / 13754370441  QQ客服:药品信息客服
浙ICP备16010490号-2 增值电信业务经营许可证:浙B2-20220931 互联网药品信息服务资格证书编号:(浙)-经营性2023-0215 浙公网安备:330683240604819103159
 医药代理商群1:药药网药品采购交流医药代理商群2:药药网药品采购交流2医药代理商群3:药药网药品采购交流3